Cargando…

PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings

Detalles Bibliográficos
Autores principales: Leathers, James S, Balderramo, Domingo, Prieto, Jhon, Diehl, Fernando, Gonzalez-Ballerga, Esteban, Ferreiro, Melina R., Carrera, Enrique, Barreyro, Fernando, Diaz-Ferrer, Javier, Singh, Dupinder, Mattos, Angelo Z., Carrilho, Flair, Debes, Jose D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243140/
https://www.ncbi.nlm.nih.gov/pubmed/30467514
http://dx.doi.org/10.5812/hepatmon.82345
_version_ 1783371921718509568
author Leathers, James S
Balderramo, Domingo
Prieto, Jhon
Diehl, Fernando
Gonzalez-Ballerga, Esteban
Ferreiro, Melina R.
Carrera, Enrique
Barreyro, Fernando
Diaz-Ferrer, Javier
Singh, Dupinder
Mattos, Angelo Z.
Carrilho, Flair
Debes, Jose D.
author_facet Leathers, James S
Balderramo, Domingo
Prieto, Jhon
Diehl, Fernando
Gonzalez-Ballerga, Esteban
Ferreiro, Melina R.
Carrera, Enrique
Barreyro, Fernando
Diaz-Ferrer, Javier
Singh, Dupinder
Mattos, Angelo Z.
Carrilho, Flair
Debes, Jose D.
author_sort Leathers, James S
collection PubMed
description
format Online
Article
Text
id pubmed-6243140
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-62431402018-11-20 PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings Leathers, James S Balderramo, Domingo Prieto, Jhon Diehl, Fernando Gonzalez-Ballerga, Esteban Ferreiro, Melina R. Carrera, Enrique Barreyro, Fernando Diaz-Ferrer, Javier Singh, Dupinder Mattos, Angelo Z. Carrilho, Flair Debes, Jose D. Hepat Mon Article 2018-10-21 2018-10 /pmc/articles/PMC6243140/ /pubmed/30467514 http://dx.doi.org/10.5812/hepatmon.82345 Text en http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Article
Leathers, James S
Balderramo, Domingo
Prieto, Jhon
Diehl, Fernando
Gonzalez-Ballerga, Esteban
Ferreiro, Melina R.
Carrera, Enrique
Barreyro, Fernando
Diaz-Ferrer, Javier
Singh, Dupinder
Mattos, Angelo Z.
Carrilho, Flair
Debes, Jose D.
PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
title PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
title_full PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
title_fullStr PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
title_full_unstemmed PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
title_short PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
title_sort pib: a score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243140/
https://www.ncbi.nlm.nih.gov/pubmed/30467514
http://dx.doi.org/10.5812/hepatmon.82345
work_keys_str_mv AT leathersjamess pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT balderramodomingo pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT prietojhon pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT diehlfernando pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT gonzalezballergaesteban pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT ferreiromelinar pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT carreraenrique pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT barreyrofernando pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT diazferrerjavier pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT singhdupinder pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT mattosangeloz pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT carrilhoflair pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings
AT debesjosed pibascoretoselectsorafenibtreatmentcandidatesforhepatocellularcarcinomainresourcelimitedsettings